Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. [Phase 1, Phase 2]
A Phase 1a/1b clinical trial evaluating TILT-123 (oncolytic adenovirus) with pembrolizumab, and with pegylated liposomal doxorubicin, for pl…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [EARLY_Phase 1]
This clinical trial update reports the completion of an early-phase Phase 1 vaccine therapy trial for patients with Stage IIIC-IV ovarian ep…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating mirvetuximab soravtansine with carboplatin for FRα-expressing, platinum-sensitive epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating senaparib in combination with temozolomide for ARID1A mutation–associated ovarian cancer and related perit…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of stereotactic body radiation therapy for recurrent primary ovarian or uterine cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating quality of life after hyperthermic intraperitoneal chemotherapy in advanced ovarian, fallopian tube, and primary pe…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Study of Sovilnesib in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study update of Sovilnesib in gynecologic cancers; the trial is active but not recruiting, investigating high-grade serous ovarian c…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial [Phase 2]
Phase 2 trial evaluating Folate Receptor Alpha Dendritic Cells (FRαDCs) vs placebo for stage III/IV ovarian, fallopian tube, or primary peri…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) [Phase 3]
Phase 3 trial MATAO is evaluating maintenance therapy with an aromatase inhibitor in epithelial ovarian cancers; the study is currently recr…
-
CLINICAL_TRIALS withdrawal · 2025-09-23Clinical Trial Update: REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 [Phase 2, Phase 3]
The REFRaME-O1 trial evaluating Luveltamab Tazevibulin versus investigator's choice chemotherapy for FOLR1-expressing ovarian cancer and rel…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer [Phase 1]
Phase 1 study evaluating STRO-002 in combination with bevacizumab for epithelial ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating the combination of durvalumab and tremelimumab in participants with recurrent or treatment-refractory ovarian, fa…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating pembrolizumab in combination with the DPX-Survivac vaccine and cyclophosphamide for advanced ova…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Nudge to Gynecologic Oncology [NA]
A clinical trial update indicating the gynecologic oncology study is currently active but not recruiting, with conditions including ovarian …
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with carboplatin for recurrent ovarian cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial comparing niraparib alone to niraparib plus bevacizumab in advanced ovarian, fallopian tube, and peritoneal cancers is curre…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial is evaluating first-line treatment with carboplatin plus mirvetuximab soravtansine for advanced-stage ovarian, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) [Phase 3]
A Phase 3 study assessing nemvaleukin alfa in combination with pembrolizumab for platinum-resistant ovarian cancer has been terminated. Resu…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating outcomes after secondary cytoreductive surgery with or without carboplatin-based HIPEC, followed by systemic chemot…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers [Phase 2]
Phase 2 clinical trial update evaluating cryocompression with or without cilostazol to prevent paclitaxel-induced neuropathy in gynecologic …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers [Phase 1]
This clinical trial update summarizes the Phase 1 study of STRO-002, an anti-Folate Receptor Alpha antibody-drug conjugate, in ovarian and e…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial of FT538 for recurrent ovarian, fallopian tube, and primary peritoneal cancer has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a T-cell therapy in combination with nivolumab, relatlimab, and ipilimumab in metastatic ovarian cancer and rel…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [NA]
A Mayo Clinic–sponsored clinical trial evaluating prehabilitation for patients with advanced ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…